We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+20.52%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$1.42B
Cap. Flow
-$217M
Cap. Flow %
-2.01%
Top 10 Hldgs %
22.86%
Holding
302
New
45
Increased
79
Reduced
106
Closed
36

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$73.2M
2
SNPS icon
Synopsys
SNPS
+$63.3M
3
GPN icon
Global Payments
GPN
+$55.9M
4
TFX icon
Teleflex
TFX
+$54.3M
5
A icon
Agilent Technologies
A
+$47.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$160M
2
UNH icon
UnitedHealth
UNH
+$122M
3
MDT icon
Medtronic
MDT
+$90M
4
HUM icon
Humana
HUM
+$52M
5
LOXO
Loxo Oncology, Inc
LOXO
+$50M

Sector Composition

Rank Sector Weight
1 Technology 26.76%
2 Financials 21.83%
3 Healthcare 19.84%
4 Communication Services 8.39%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
126
Molina Healthcare
MOH
$10.5B
$28.5M 0.26%
+200,511
New +$27.1M
FCX icon
127
Freeport-McMoran
FCX
$88.6B
$28.1M 0.26%
2,180,338
– –
EG icon
128
Everest Group
EG
$15.8B
$28.1M 0.26%
130,000
+13,000
+11% +$2.83M
NEWR
129
DELISTED
New Relic, Inc.
NEWR
$27.6M 0.26%
279,383
-160,598
-37% -$15.9M
SRPT icon
130
Sarepta Therapeutics
SRPT
$1.63B
$27.3M 0.25%
229,365
+28,883
+14% +$3.71M
ZGNX
131
DELISTED
Zogenix, Inc.
ZGNX
$26.7M 0.25%
484,569
+150,000
+45% +$7.14M
SPLK
132
DELISTED
Splunk Inc
SPLK
$26.4M 0.25%
212,223
-162,540
-43% -$20.3M
GWPH
133
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$26.2M 0.24%
155,658
+105,658
+211% +$15.7M
DBX icon
134
Dropbox
DBX
$7.48B
$25.2M 0.23%
1,156,037
-475,707
-29% -$11.1M
BNFT
135
DELISTED
Benefitfocus, Inc.
BNFT
$25M 0.23%
503,854
+200,000
+66% +$10.2M
STML
136
DELISTED
Stemline Therapeutics, Inc.
STML
$24.4M 0.23%
1,900,000
-402,666
-17% -$4.55M
FICO icon
137
Fair Isaac
FICO
$31B
$24.3M 0.23%
+89,305
New +$21M
ADI icon
138
Analog Devices
ADI
$178B
$23.5M 0.22%
+222,772
New +$22.4M
ALTR
139
DELISTED
Altair Engineering Inc
ALTR
$22.3M 0.21%
605,794
-130,050
-18% -$4.37M
MDT icon
140
Medtronic
MDT
$111B
$22.2M 0.21%
243,680
-1,005,400
-80% -$90M
AMG icon
141
Affiliated Managers Group
AMG
$9.78B
$22.1M 0.2%
205,925
+435
+0.2% +$46.2K
AUPH icon
142
Aurinia Pharmaceuticals
AUPH
$1.92B
$21.5M 0.2%
3,312,723
– –
PPLI
143
People Inc
PPLI
$3.13B
$21.2M 0.2%
565,388
+57,073
+11% +$2.11M
RLI icon
144
RLI Corp
RLI
$5.97B
$20.9M 0.19%
583,000
-24,000
-4% -$827K
MYOK
145
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$20.8M 0.19%
400,000
+191,807
+92% +$8.84M
SAGE
146
DELISTED
Sage Therapeutics
SAGE
$19.9M 0.18%
125,000
+95,000
+317% +$13.8M
PRA
147
DELISTED
ProAssurance
PRA
$19.6M 0.18%
565,800
-9,500
-2% -$385K
AZPN
148
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$19.5M 0.18%
187,441
+44,135
+31% +$4.6M
AFL icon
149
Aflac
AFL
$65.9B
$19.4M 0.18%
388,000
-29,000
-7% -$1.4M
MDC
150
DELISTED
M.D.C. Holdings, Inc.
MDC
$19.2M 0.18%
712,512
-60,824
-8% -$1.61M
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Polar Capital held 302 positions worth $10.8B, up 15% from $9.35B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital's Q1 2019 filing shows 45 new, 79 increased, 106 reduced and 36 closed positions. Its largest new stake was Global Payments: 460,457 shares worth $62.9M. The largest sale was Johnson & Johnson, an estimated $160M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Polar Capital's largest Q1 2019 buy was Global Payments: 460,457 shares worth $62.9M.
  • Polar Capital added most to Merck in Q1 2019, an estimated $73.2M increase.
  • Polar Capital's biggest Q1 2019 reduction was Johnson & Johnson, cutting an estimated $160M.
  • Polar Capital fully exited UnitedHealth in Q1 2019, selling an estimated $122M.
  • Polar Capital's ten largest holdings make up 23% of its $10.8B portfolio in Q1 2019.
  • Polar Capital opened 45 new positions and closed 36 in Q1 2019.
  • Polar Capital's portfolio value rose 15% quarter-over-quarter to $10.8B.

Based on Polar Capital's 13F filing for Q1 2019, filed 15 May 2019.